South Korea's Daewoong Pharmaceutical has reportedly claimed that the experimental anti viral drug Niclosamide eliminated the novel COVID-19 from animals lungs during the clinical trials. The South Korean Pharmaceutical company claimed that the drug completely cured the Coronavirus disease in the lungs of the ferrets and healed the inhibited inflammation, one of the most dangerous symptoms of the COVID19 that caused respirtoey distress in the humans.
As pharma companies all over the world scramble to develop treatment and vaccines for the Coronavirus that has consumed over 409,300 lives, Daewoong said Niclosamide was effective in the cure of the respiratory disease that originated in the chinese city of Wuhan, Hubei province of China in December 2018.
As per the sources, the pharma company plans to start human clinical trials in July and is certain that Niclosamide could be the COVID-19 treatment. Further, at least three more companies have been conducting similar tests for the drug administered orally, worldwide.
In a trial test, the ferrets were given the drug and observed for at least three months, Niclosamide's preliminary results able to target the COVID-19 directly not only from having a safe harbour in the patient's body, but eliminating the virus completely, as per reported by the media.
CEO of Daewoong Pharma, jeon Seng-ho, was quoted saying, based on the positive result from the animal test, the firm now plans to complete human trials and get the approval of the Coronavirus treatment drug by the end of this year.